In recent years, evidence has showed that leukotrienes play a role in the pathogenesis of AD. Montelukast, one of leukotrienes receptor antagonists, has been used to treat the patients with AD. The up-date of montelukast in the treatment of AD was reviewed in this paper.%近年来,有证据表明白三烯在特应性皮炎的发病机制中有一定作用,并有学者试用白三烯受体拮抗剂治疗特应性皮炎,孟鲁司特是白三烯受体拮抗剂中最具代表性药物,本文就孟鲁斯特在特应性皮炎中的研究进展作一综述.
展开▼